ANDA 75681, held by Teva Pharms. Megestrol Acetate.
As of Nov 15, 2026, ANDA 75681 (Megestrol Acetate), held by Teva Pharms, was first approved by FDA on May 5, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 5, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Megestrol Acetate40MG/ML ยท suspension;oral | Megestrol Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
